(Q39331609)

11 September 2017

Susceptibility of diverse primary HIV isolates with varying co-receptor specificity's to CXCR4 antagonistic compounds (English)

1 reference

11 September 2017

0 references

Dominique Schols

3

0 references

Naoki Yamamoto

series ordinal

5

object named as

Naoki Yamamoto

1 reference

11 September 2017

6

Renu B Lal

1 reference

11 September 2017

Sherry M Owen

1

1 reference

PubMed ID

12210401

11 September 2017

Donna Rudolph

series ordinal

2

1 reference

PubMed ID

12210401

11 September 2017

Nobutaka Fujii

series ordinal

4

1 reference

11 September 2017

1 October 2002

1 reference

Journal of Medical Virology

11 September 2017

1 reference

11 September 2017

68

1 reference

11 September 2017

147-155

1 reference

11 September 2017

2

1 reference

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

11 September 2017

1 reference

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

21 January 2018

1 reference

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker

21 January 2018

1 reference

Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4

21 January 2018

1 reference

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

21 January 2018

1 reference

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

21 January 2018

1 reference

Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency.

21 January 2018

1 reference

Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4.

21 January 2018

1 reference

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

21 January 2018

1 reference

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

21 January 2018

1 reference

Co-receptors for HIV-1 entry

21 January 2018

1 reference

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

21 January 2018

1 reference

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells

21 January 2018

1 reference

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

21 January 2018

1 reference

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

21 January 2018

1 reference

Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease

21 January 2018

1 reference

Assays for retroviral reverse transcriptase

21 January 2018

1 reference

CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.

21 January 2018

1 reference

Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression

21 January 2018

1 reference

Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users

21 January 2018

1 reference

Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells

21 January 2018

1 reference

Partial Resistance to Infection by R5X4 Primary HIV Type 1 Isolates in an Exposed-Uninfected Individual Homozygous for CCR5 32-Base Pair Deletion

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.10191

1 reference

11 September 2017

1 reference

PubMed ID

12210401